Abstract:Objectives: Microvascular obstruction (MVO) is a specific cardiac magnetic resonance (CMR) imaging feature in patients with acute myocardial infarction. The purpose of this study was to elucidate the predictive value of MVO in left ventricular adverse remodeling after primary percutaneous coronary intervention (PCI) in patients with acute ST-elevation myocardial infarction (STEMI). Methods: A total of 167 patients with STEMI undergoing primary PCI in the Chinese PLA General Hospital from 2016 to 2020 were enrolled in this prospective cohort study, the average age of study patients was 57±10 years old, with 151 males (90.4%) and 16 females (9.6%). The patients were divided into the MVO group (n=81) and non-MVO group (n=86) according to the presence or absence of MVO on CMR imaging, respectively. The primary endpoint of the study was the occurrence of left ventricular adverse remodeling, which was defined as an increase in left ventricular end diastolic volume (LVEDV) by >20% at 6 months after primary PCI compared with the baseline. Patients who completed follow-up were diagnosed as left ventricular adverse remodeling or no left ventricular adverse remodeling according to CMR. The baseline data, perioperative data, and related data of end points were compared between the MVO group and non-MVO group. Finally, the predictive value of MVO in left ventricular adverse remodeling was calculated by receiver operating characteristic curve analysis. Results: In the baseline data, preoperative thrombolysis in myocardial infarction (TIMI) flow (χ2=13.74, P=0.003) and postoperative TIMI flow (χ2=14.87, P=0.001) were both obviously decreased in the MVO group. After 6 months of follow-up, the incidence of left ventricular adverse remodeling in the MVO group was significantly higher than that in the non-MVO group [37.0%(27/73) vs. 18.9%(14/74), χ2=5.96, P=0.015]. The left ventricular end systolic volume at 6 months post infarction in the MVO group was significantly larger than that in the non-MVO group [(94±32) vs. (68±20) ml, t=-5.98, P<0.001], as well as the LVEDV [(169±38) vs. (143±29) ml, t=-4.74, P<0.001]. Receiver operating characteristic curve showed that the area under the curve of MVO size for predicting left ventricular adverse remodeling was 0.637. Conclusion: The risk of left ventricular adverse remodeling is significantly increased in patients with MVO after primary PCI for acute STEMI.

Left Ventricular Remodeling with Preserved Function after Coronary Microembolization: the Effect of Methylprednisolone.

Mast Cell Contributes to Cardiomyocyte Apoptosis after Coronary Microembolization

[Effect of acute coronary microembolization on microvascular injury and myocardial endothelin-1 levels].

Assessment of the Acute Effects of Glucocorticoid Treatment on Coronary Microembolization Using Cine, First-Pass Perfusion, and Delayed Enhancement Mri

Effect of Breviscapine on Recovery of Viable Myocardium and Left Ventricular Remodeling in Chronic Total Occlusion Patients after Revascularization: Rationale and Design for a Randomized Controlled Trial

Glucocorticoid Ameliorates Early Cardiac Dysfunction after Coronary Microembolization and Suppresses TGF-β1/Smad3 and CTGF Expression.

Changes in left ventricular ejection fraction and coronary flow reserve after coronary microembolization.

Effects of Mesenchymal Stem Cells Transplantation on Post-Infarction Ventricular Remodeling in Rats

[A Prospective, Randomized, Controlled Trial of Autologous Mesenchymal Stem Cells Transplantation for Dilated Cardiomyopathy].

Proteomics Analysis of Myocardial Tissues in a Mouse Model of Coronary Microembolization

Advances in MicroRNA-Mediated Regulation of Cardiomyocyte Injury after Coronary Microembolization

Abstract 13434: Cardioprotection of Rosuvastatin Against Cardiac Dysfunction after Coronary Microembolization Via Alleviating Inflammatory Induced Microinfarctions

Effect of Microembolization on Left Ventricular Systolic Wall Motion and Dyssynchrony Using Dipyridamole Stress Two-dimensional Speckle Tracking Imaging: an Experimental Study

Menstrual Blood Stem Cells Attenuate Post-Infarction Myocardial Fibrosis Via Inhibiting Endothelial to Mesenchymal Transition (Endmt)

Transplantation of Endothelial Progenitor Cells in the Treatment of Coronary Artery Microembolism in Rats

Effect of Intracoronary Autologous Bone Marrow Stem Cells Transfer on Left Ventricular Function after Acute Myocardial Infarction

Effects of Methylprednisolone on Myocardial Function and Microcirculation in Post-resuscitation: A Rat Model

Changes of Coronary Flow Reserve and Myocardial Blood Flow after Coronary Microembolization

[The predictive value of microvascular obstruction for adverse left ventricular remodeling after primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a prospective study]

Abstract 13957: TNF-α/MiR-133a Involved in Myocardial Leukocytes Infiltration and Cardiac Dysfunction on the Early Phase of Coronary Microembolization

P573Evaluation of Left Atrial Remodeling and Function of End-Stage Renal Disease with Preserved Left Ventricular Ejection Fraction